Swim through the sea of acronyms as Dr Scott Matherly (@liverprof) helps us become a little less baffled by the thought of NAFLD. We discuss the initial diagnosis of fatty liver disease, indications for additional evaluation with imaging and/or biopsy, and potential treatment options. With a quarter of the world affected, it’s crucial to understand the various forms of disease and how to counsel patients about this all-too-common condition!

Credits

Written and Produced by: Elena Gibson MD
Infographic and Cover Art: Elena Gibson MD
Hosts: Matthew Watto MD, FACP; Paul Williams MD, FACP
Editor: Emi Okamoto MD (written materials); Clair Morgan of nodderly.com
Guest: Scott Matherly MD

Sponsor: Pediatrics On Call

Sponsor: VCU Health Continuing Education to offer continuing education credits for physicians and other healthcare professionals. Check out curbsiders.vcuhealth.org and create your FREE account!

Time Stamps

00:00 Intro
03:15 Guest one-liner; Picks of the Week* :
08:15 Sponsor
08:50 Case from Kashlak part 1; What is hepatic steatosis?
11:43 NAFLD acronyms and definitions
18:20 Alcohol and Fatty Liver
23:15 Initial Evaluation of NAFLD
35:12 Dr Matherly’s piel to patients with fatty
41:11 NASH/Fibrosis Risk Assessment
48:54 Outcomes in NASH with Fibrosis
51:20 Statins are safe in liver disease
56:15 Treatment Options (surgery, Vitamin E, Pioglitazone, SLGT2 inhibitors and GLP1 agonists; Coffee?!)
71:42 Take home points and Outro

#227 Baffled by NAFLD?

The Curbsiders Internal Medicine Podcast